AIG
KALV

American International Group’s KalVista Pharmaceuticals KALV Stock Holding History

American International Group’s Portfolio KALV Stock Details KALV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-15,431
Closed -$183K – 1389
2024
Q1 		$183K Buy
15,431
+42
+0.3% +$560 ﹤0.01% 2198
2023
Q4 		$189K Buy
15,389
+3,099
+25% +$28.2K ﹤0.01% 2203
2023
Q3 		$118K Buy
12,290
+437
+4% +$4.46K ﹤0.01% 2414
2023
Q2 		$107K Buy
11,853
+39
+0.3% +$360 ﹤0.01% 2534
2023
Q1 		$92.9K Buy
11,814
+235
+2% +$1.75K ﹤0.01% 2491
2022
Q4 		$78.3K Sell
11,579
-42
-0.4% -$225 ﹤0.01% 2611
2022
Q3 		$169K Buy
11,621
+165
+1% +$2.31K ﹤0.01% 2255
2022
Q2 		$113K Buy
11,456
+337
+3% +$3.72K ﹤0.01% 2528
2022
Q1 		$164K Sell
11,119
-782
-7% -$11.2K ﹤0.01% 2361
2021
Q4 		$157K Buy
11,901
+1,021
+9% +$16.3K ﹤0.01% 2502
2021
Q3 		$190K Sell
10,880
-259
-2% -$5.25K ﹤0.01% 2459
2021
Q2 		$267 Buy
11,139
+34
+0.3% +$890 ﹤0.01% 2325
2021
Q1 		$285 Buy
11,105
+2,619
+31% +$68.8K ﹤0.01% 2167
2020
Q4 		$161 Buy
8,486
+332
+4% +$5.69K ﹤0.01% 2392
2020
Q3 		$103K Sell
8,154
-186
-2% -$2.33K ﹤0.01% 2523
2020
Q2 		$101K Buy
8,340
+868
+12% +$9.23K ﹤0.01% 2533
2020
Q1 		$57K Sell
7,472
-431
-5% -$5.82K ﹤0.01% 2615
2019
Q4 		$141K Buy
7,903
+532
+7% +$6.94K ﹤0.01% 2428
2019
Q3 		$86K Sell
7,371
-50
-0.7% -$808 ﹤0.01% 2696
2019
Q2 		$164K Buy
+7,421
New +$174K ﹤0.01% 2362
2016
Q2 		– Sell
-513
Closed -$5K – 3831
2016
Q1 		$5K Hold
513
– – ﹤0.01% 4732
2015
Q4 		$26K Sell
513
-1
-0.2% -$52 ﹤0.01% 4188
2015
Q3 		$26K Hold
514
– – ﹤0.01% 4188
2015
Q2 		$51.4K Buy
+514
New +$51K ﹤0.01% 4039

Other funds holding KALV

VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VPC
Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return

American International Group's KALV Position: Q2 2024 in Review

American International Group sold out of KalVista Pharmaceuticals (KALV) in Q2 2024, closing a stake of 15,431 shares — an estimated $183K sold.

American International Group first reported a position in KALV in Q2 2015 and held it in 24 quarters. The position peaked at $190K in Q3 2021. 119 funds tracked by Wall St. Rank hold KALV as of Q2 2024.

  • American International Group reported no remaining KalVista Pharmaceuticals position as of Q2 2024 after selling out during the quarter.
  • American International Group sold 15,431 KalVista Pharmaceuticals shares in Q2 2024, an estimated $183K.
  • American International Group first reported a position in KalVista Pharmaceuticals in Q2 2015 and held it in 24 quarters.
  • American International Group's KalVista Pharmaceuticals position peaked at $190K in Q3 2021.
  • 119 funds tracked by Wall St. Rank held KalVista Pharmaceuticals as of Q2 2024.

Based on American International Group's 13F filing for Q2 2024, filed 13 Aug 2024.